Literature DB >> 26818469

Efficacy of an Automated Multiple Emitter Whole-Room Ultraviolet-C Disinfection System Against Coronaviruses MHV and MERS-CoV.

Kurt Bedell1, Adam H Buchaklian2, Stanley Perlman1.   

Abstract

Efficient and automated methods of disinfecting surfaces contaminated with the Middle Eastern respiratory syndrome coronavirus (MERS-CoV) may prevent the spread of the virus. Here we report the efficacy and use of an automated triple-emitter whole room UV-C disinfection system to inactivate mouse hepatitis virus, strain A59 (MHV-A59) and MERS-CoV viruses on surfaces with a >5 log10 reduction.

Entities:  

Mesh:

Year:  2016        PMID: 26818469      PMCID: PMC5369231          DOI: 10.1017/ice.2015.348

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


The virus responsible for Middle Eastern respiratory syndrome (MERS), MERS-coronavirus (CoV) is a lineage C β-coronavirus similar to the lineage A murine β-coronavirus, mouse hepatitis virus, strain A59 (MHV-A59). Coronaviruses were first identified as the causative agent of the severe acute respiratory syndrome (SARS) in 2002 in China, and the Middle Eastern respiratory syndrome (MERS) in the Middle East in 2012. – The first reported case of MERS occurred in Saudi Arabia in 2012 and resulted in 76 deaths. Since that time, cases of MERS have continued to occur in both the Middle East as well as in other countries in Europe, Asia, Africa, and North America. A recent outbreak, involving more than 180 patients, occurred in South Korea. MERS has a reported mortality rate of approximately 36%; , , it is thought to be transmitted from camels to humans through direct contact; however, obvious camel-to-human interaction has not been documented in all cases. Human-to-human transmission has also been identified in hospital and household transmission during MERS outbreaks. The ability of coronaviruses to rapidly mutate increases the risk of a large-scale outbreak or epidemic in the future. MHV-A59 is structurally similar to the MERS-CoV but causes hepatic and neuronal disease in mice. The MHV-A59 virus is an ideal model virus with which to study the effects of UV-C against MERS-CoV because it has many similarities to the human virus but can be handled at the biosafety level 2 (BSL2) laboratory. Along with studies of MHV-A59, the Surfacide multiple-emitter system (Surfacide, Naperville, IL) was also tested against the MERS-CoV virus.

METHODS

The Surfacide multiple-emitter automated UV-C disinfection system consists of 3 ultraviolet C (UV-C) emitters with a diameter of 59 cm and a height of 195 cm. All systems include both a touch screen control tablet and a motion sensor that double as jointers to connect the emitters together for transport. The system utilizes a laser to identify the size of the disinfection space and to identify near-field objects. Based on these measurements the system then calculates the disinfection cycle time accordingly while rotating 360°. Triplicate 10-µL aliquots of MHV-A59 were loaded onto sterile glass coverslips at a concentration of 1.6e8 pfu/mL and allowed to dry. Coverslips containing dried virus were then placed in a UV transparent Petri dish and either left untreated or exposed to UV-C radiation from the Surfacide system placed 4 feet (1.22 m) from the samples for predetermined times between 0 and 60 minutes. The coverslips containing dried virus were then placed in Dulbecco’s Modified Eagle’s Medium (DMEM) media on ice to resuspend the virus. Serial 1:10 dilutions were inoculated onto Hela cells expressing the MHV receptor and allowed to incubate for 45 minutes at 37°C. Medium containing virus was removed and the cells were allowed to incubate overnight in D10 media. Plaque counts were determined the following day by combining 1% neutral red with 2× media plus agarose and incubating the cells for approximately 3 hours. All studies were conducted in triplicate with replicate experiments. Testing MERS-CoV sensitivity to UV-C was conducted under strict containment BSL3 laboratory protocols due to the infective nature of the virus, and all steps were carried out above bleach-soaked pads to prevent virus spread. The moist environment created by the bleach soaked pads in the biosafety cabinet prevented drying of the virus onto glass coverslips. MERS-CoV was therefore loaded onto glass coverslips as small droplets at a concentration of 8.9e5 pfu/mL in UV-C permeable dishes and exposed to UV-C energy from the Surfacide emitter placed 4 feet (1.22 m) from the dishes. Samples were removed at several time points between 0 and 30 minutes. Virus resuspension and dilution were carried out as described above. Virus dilutions were placed onto 90% confluent African green monkey kidney cell-line (Vero81) cells at 37°C for 40 minutes. Following a 40-minute incubation, medium containing virus was removed and replaced with 2×medium plus 1.2% agarose and allowed to solidify. DMEM was then layered on top to prevent drying, and the plates were incubated at 37°C for 3 days to allow plaque formation. On day 3, formalin was added to fix the cells for 20 minutes. Formalin, media, and agarose were then removed and replaced with 0.1% crystal violet for a 5-minute incubation. This procedure was followed by a phosphate-buffered saline (PBS) wash prior to counting plaques. Again, all samples were prepared in triplicate.

RESULTS

MHV-A59 dried and MERS-CoV droplets were stable on glass coverslips for at least 60 and 30 minutes, 0.09 and 0.22 log reduction, respectively. Plaque counts indicated that the UV-C energy emitted from the Surfacide disinfection system was able to reduce the viral titers of MHV-A59 by an average of 2.71 log10 in 5 minutes and 6.11 log10 in 10 minutes of exposure, resulting in undetectable levels of MHV-A59 virus (Figure 1). For MERS-CoV, a UV-C exposure time of only 5 minutes resulted in undetectable virus levels that remained undetectable following 30 minutes of total exposure for a 5.9 log10 reduction (Figure 2).
FIGURE 1

Log reduction of MHV-A59 following Surfacide UV-C exposure at a 4-foot distance (1.22 m). Virus was reduced by 2.71 log10 in 5 minutes and by 6.11 log10 in 10 minutes to undetectable levels. Results are the means of triplicate samples.

FIGURE 2

Log reduction of MERS-CoV during exposure to Surfacide UV-C at 4 feet (1.22 m). Log reduction of MERS-CoV on glass coverslips following Surfacide UV-C exposure at a 4-foot distance. Virus was reduced to 5.91 log10 in 5 minutes to undetectable levels. Results are the means of triplicate samples.

Log reduction of MHV-A59 following Surfacide UV-C exposure at a 4-foot distance (1.22 m). Virus was reduced by 2.71 log10 in 5 minutes and by 6.11 log10 in 10 minutes to undetectable levels. Results are the means of triplicate samples. Log reduction of MERS-CoV during exposure to Surfacide UV-C at 4 feet (1.22 m). Log reduction of MERS-CoV on glass coverslips following Surfacide UV-C exposure at a 4-foot distance. Virus was reduced to 5.91 log10 in 5 minutes to undetectable levels. Results are the means of triplicate samples.

DISCUSSION

The multiple-emitter continuous UV-C disinfection system was >99.999% effective against MHV-A59, a mouse analog of MERS-CoV, and SARS-CoV in 10 minutes. Applying those same studies to droplets of MERS-CoV resulted in undetectable levels of MERS-CoV virus after only 5 minutes of exposure to the UV-C emitter or a percent reduction of >99.999%. Notably, UV-C disinfection is most effective when used as an adjunct to standard terminal cleaning of hard surfaces and should not be used to replace good cleaning practices. This study is the first to document the effectiveness of a multiple-emitter, automated, whole-room UV-C system or any whole-room disinfection system against RNA viruses like MHV-A59, MERS-CoV, and SARS-CoV. The use of the Surfacide whole-room UV-C disinfection system during MERS outbreaks may prevent the nosocomial spread of the virus and protect staff in the process.
  8 in total

1.  Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins.

Authors:  R K Williams; G S Jiang; K V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Lessons to learn from MERS-CoV outbreak in South Korea.

Authors:  Adnan Khan; Amber Farooqui; Yi Guan; David J Kelvin
Journal:  J Infect Dev Ctries       Date:  2015-07-04       Impact factor: 0.968

3.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

4.  Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.

Authors:  Raoul J de Groot; Susan C Baker; Ralph S Baric; Caroline S Brown; Christian Drosten; Luis Enjuanes; Ron A M Fouchier; Monica Galiano; Alexander E Gorbalenya; Ziad A Memish; Stanley Perlman; Leo L M Poon; Eric J Snijder; Gwen M Stephens; Patrick C Y Woo; Ali M Zaki; Maria Zambon; John Ziebuhr
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

5.  Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device.

Authors:  Deverick J Anderson; Maria F Gergen; Emily Smathers; Daniel J Sexton; Luke F Chen; David J Weber; William A Rutala
Journal:  Infect Control Hosp Epidemiol       Date:  2013-05       Impact factor: 3.254

Review 6.  Advances in clinical diagnosis and treatment of severe acute respiratory syndrome.

Authors:  Qing-He Nie; Xin-Dong Luo; Wu-Li Hui
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 7.  Middle East respiratory syndrome.

Authors:  Alimuddin Zumla; David S Hui; Stanley Perlman
Journal:  Lancet       Date:  2015-06-03       Impact factor: 79.321

8.  Middle East respiratory syndrome coronavirus (MERS-CoV): A cluster analysis with implications for global management of suspected cases.

Authors:  Ziad A Memish; Jaffar A Al-Tawfiq; Rafat F Alhakeem; Abdullah Assiri; Khalid D Alharby; Maher S Almahallawi; Mohammed Alkhallawi
Journal:  Travel Med Infect Dis       Date:  2015-07-15       Impact factor: 6.211

  8 in total
  38 in total

1.  Ultraviolet-C and other methods of decontamination of filtering facepiece N-95 respirators during the COVID-19 pandemic.

Authors:  Angeli Eloise Torres; Alexis B Lyons; Shanthi Narla; Indermeet Kohli; Angela Parks-Miller; David Ozog; Iltefat H Hamzavi; Henry W Lim
Journal:  Photochem Photobiol Sci       Date:  2020-05-15       Impact factor: 3.982

2.  UVB (290-315 nm) inactivation of the SARS CoV-2 virus as a function of the standard UV index.

Authors:  Jay Herman; Rubén D Piacentini
Journal:  Air Qual Atmos Health       Date:  2021-11-04       Impact factor: 3.763

Review 3.  UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses.

Authors:  Sanjeev K Bhardwaj; Harpreet Singh; Akash Deep; Madhu Khatri; Jayeeta Bhaumik; Ki-Hyun Kim; Neha Bhardwaj
Journal:  Sci Total Environ       Date:  2021-06-16       Impact factor: 7.963

4.  Principles of Disinfectant Use and Safety Operation in Medical Facilities During Coronavirus Disease 2019 (COVID-19) Outbreak.

Authors:  Gen Takagi; Kazuyoshi Yagishita
Journal:  SN Compr Clin Med       Date:  2020-07-18

Review 5.  The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review.

Authors:  F Chiappa; B Frascella; G P Vigezzi; M Moro; L Diamanti; L Gentile; P Lago; N Clementi; C Signorelli; N Mancini; A Odone
Journal:  J Hosp Infect       Date:  2021-05-21       Impact factor: 3.926

6.  Sample sizes for surveillance of S. aureus transmission to monitor effectiveness and provide feedback on intraoperative infection control including for COVID-19.

Authors:  Franklin Dexter; Johannes Ledolter; Russell T Wall; Subhradeep Datta; Randy W Loftus
Journal:  Perioper Care Oper Room Manag       Date:  2020-05-21

7.  Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study.

Authors:  Xin-Ying Zhao; Xuan-Xuan Xu; Hai-Sen Yin; Qin-Ming Hu; Tao Xiong; Yuan-Yan Tang; Ai-Ying Yang; Bao-Ping Yu; Zhi-Ping Huang
Journal:  BMC Infect Dis       Date:  2020-04-29       Impact factor: 3.090

Review 8.  Winter Is Coming: A Southern Hemisphere Perspective of the Environmental Drivers of SARS-CoV-2 and the Potential Seasonality of COVID-19.

Authors:  Albertus J Smit; Jennifer M Fitchett; Francois A Engelbrecht; Robert J Scholes; Godfrey Dzhivhuho; Neville A Sweijd
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

Review 9.  Unlocking the surge in demand for personal and protective equipment (PPE) and improvised face coverings arising from coronavirus disease (COVID-19) pandemic - Implications for efficacy, re-use and sustainable waste management.

Authors:  Neil J Rowan; John G Laffey
Journal:  Sci Total Environ       Date:  2020-09-10       Impact factor: 7.963

10.  The importance of the minimum dosage necessary for UVC decontamination of N95 respirators during the COVID-19 pandemic.

Authors:  Shanthi Narla; Alexis B Lyons; Indermeet Kohli; Angeli E Torres; Angela Parks-Miller; David M Ozog; Iltefat H Hamzavi; Henry W Lim
Journal:  Photodermatol Photoimmunol Photomed       Date:  2020-04-28       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.